FUNDAMENTALS · Fundamentals · KR Healthcare

P&S Robotics (460940) Fundamentals 2026 — P/E 17.0x, Revenue Analysis | SniperIQ

P&S Robotics (460940) is a KR-listed Healthcare company in Medical - Specialties with a market capitalization of ₩59.4B, trading at ₩4415.00 on the KOE. This SniperIQ fundamentals page covers P&S Robotics's valuation (P/E 17.0x, P/B 1.4x), profitability (net margin 34.3%), revenue (₩7.6B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.

Market Cap₩59.4B
P/E (TTM)17.0x
Net Margin34.3%
Revenue (FY25)₩7.6B

Full research coverage

  • 8-Quarter Revenue & Margin Trend
  • Debt Maturity & Coverage
  • Peer Valuation Comparison
  • Free Cash Flow & Owner Earnings
  • AI Signal + Institutional Flow
  • DCF Valuation Model

Frequently Asked Questions

What is P&S Robotics's market cap?

P&S Robotics (460940) has a market capitalization of approximately ₩59.4B, trading at ₩4415.00 on the KOE. Market cap moves with the live share price.

What is P&S Robotics's P/E ratio?

P&S Robotics's trailing twelve-month P/E ratio is 17.0x, with a price-to-book (P/B) of 1.4x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.

How profitable is P&S Robotics?

P&S Robotics runs a net profit margin of 34.3%, a gross margin of 64.2%, and an operating margin of 5.6%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.

How much revenue does P&S Robotics generate?

P&S Robotics reported revenue of ₩7.6B for fiscal year 2025, with net income of ₩2.7B and earnings per share (EPS) of 211.52. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.

Does P&S Robotics pay a dividend?

P&S Robotics offers a trailing dividend yield of about 0.9%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.

Is P&S Robotics financially healthy?

P&S Robotics carries a debt-to-equity ratio of 0.02x and a current ratio of 28.48x, with a market beta of 0.45. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.

Is P&S Robotics a good stock to buy in 2026?

SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For P&S Robotics (460940) the key facts are: market cap ₩59.4B, P/E 17.0x, revenue ₩7.6B, 52-week range 3840-14800. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.

Track P&S Robotics's full fundamentals live

Get P&S Robotics's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.

Related: Shilpa Medicare (SHILPAMED) fundamentals · Shanghai Allist Pharmaceuticals (688578) fundamentals · Sugentech (253840) fundamentals · Cencora (COR) fundamentals · All stock fundamentals · AI signal library
Research Hubs: Fundamentals library · Screeners · Institutional positioning · Super investors · Daily signals · Platform comparisons